Chin Peter Scott sold DNLI
September 4, 2026 · Form 4 insider transaction
Chin Peter Scott sold 1,654 shares of Denali Therapeutics Inc. at $22.29 per share, a transaction worth $36.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.; The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.28 to $22.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.; Includes 142,845 Unvested RSU's; Includes 1,790 shares acquired under the ESPP Purchase on June 1, 2026.